XML 38 R28.htm IDEA: XBRL DOCUMENT v3.22.1

New Drug Application (Details Narrative)	3 Months Ended
New Drug Application (Details Narrative)	Mar. 31, 2022 USD ($)
R&D expense	$ 3,117,218

X

- References

No definition available.

+ Details

Name:	nymox_ResearchAndDevelopmentExpense1
Namespace Prefix:	nymox_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration